Leading nylon producer INVISTA and LanzaTech signed a research and development agreement focused on the development of gas-fermentation process technology for the production of industrial chemicals from carbon dioxide and hydrogen gas feedstocks using proprietary INVISTA host organisms and metabolic pathways. If successful, the first commercialization of this technology is expected as early as 2018.
The new agreement builds on INVISTA’s existing collaborations with LanzaTech (earlier post), and will provide INVISTA increased access to LanzaTech’s gas-fermentation process technology and help accelerate the commercialization of a number of exciting bio-derived processes currently under development at INVISTA’s bioscience laboratory, said Warren Primeaux, president of INVISTA Intermediates.
In 2012, INVISTA and LanzaTech signed a joint development agreement focused on bio-based butadiene, with initial commercialization expected in 2016.
INVISTA believes biotechnology has the potential to significantly improve the cost and availability of several chemicals and raw materials that are used to produce its current products. It views gas fermentation as a key enabling technology that will allow the use of potentially advantaged gas feedstocks—such as waste industrial gases including carbon dioxide.
INVISTA is one of the world’s leading integrated producers of chemical intermediates, polymers and fibers. The company’s advantaged technologies for nylon, spandex and polyester are used to produce clothing, carpet, car parts and other products.